Skip to main content

9.

Survival analysis of patients with single IRF or no risk factors receiving AT

Variables All (n) AT [n (%)] Observation [n (%)] P
OS DFS
IRF, intermediate-risk factor; AT, adjuvant therapy; LVSI, lymphovascular space invasion ; DSI, deep stromal invasion; OS, overall survival; DFS, disease-free survival.
Single IRF 473 288 (60.9) 185 (39.1) 0.273 0.197
LVSI only 100 91 (91.0) 9 (9.0) 0.146 0.785
DSI only 132 116 (87.9) 16 (12.1) 0.708 0.866
G3 only 172 97 (56.4) 75 (43.6) 0.799 0.750